Trestle bridge

Teampay Brings Total Funding to $65 Million with Latest Round Led by Fin Venture Capital

Retrieved on: 
Wednesday, November 30, 2022
Start-Up, Banking, Accounting, Technology, Professional Services, Payments, Software, Other Professional Services, Internet, Fintech, Finance, Spend, LGBTQ, Marketing, Growth, Software, CFO, Kayal, Accounting, Venture round, CFOS, Engineering, Certification, Enterprise Products, Partnership, Acquisition, The Shyft Group, Policy, Software as a service, Travel, Great Places, Consumption (economics), Betterment, Electricity, Mastercard, Investment, Silver, Customer success, Financial services, Management, Renewable energy, Video game, Trestle bridge, Cherré

Teampay , the all-in-one-purchasing platform, today announced it raised $47 million in Series B funding led by existing investor Fin Venture Capital.

Key Points: 
  • Teampay , the all-in-one-purchasing platform, today announced it raised $47 million in Series B funding led by existing investor Fin Venture Capital.
  • New investors Mastercard, Proof Ventures, Trestle, and Espresso Capital supported the oversubscribed round, bringing Teampays total funding to $65M.
  • As part of this latest round of funding, Teampay will expand its partnership with Mastercard to accelerate its go-to-market strategy.
  • With this deeper collaboration, Mastercard and Teampay will mutually explore opportunities to enhance product capabilities at scale.

Trestle Biotherapeutics Announces Formation of Advisory Board

Retrieved on: 
Wednesday, February 23, 2022
Biotechnology, Hospitals, Genetics, Health, Entrepreneurship, Massachusetts General Hospital, Harvard Medical School, Faculty, Wyss Institute, Eli, Bionics, Kidney, Department, Hospital, University, Tissue engineering, Laboratory, Wyss Institute for Biologically Inspired Engineering, Transplant, Stem cell, Engineering, Nephrology, Regenerative medicine, Coronavirus Scientific Advisory Board (Turkey), Patient, Harvard University, Drug discovery, Wyss, AV, HAV, Developmental biology, Bioinspiration, Kidney failure, Protalix BioTherapeutics, CEO, Pharmaceutical industry, Management, Brigham, Trestle bridge

Trestle Biotherapeutics, a private, San Diego-based company developing bioengineered therapies for patients living with kidney failure today announced the formation of its advisory board.

Key Points: 
  • Trestle Biotherapeutics, a private, San Diego-based company developing bioengineered therapies for patients living with kidney failure today announced the formation of its advisory board.
  • The Trestle Advisory Board is a balanced mix of academic and industry leaders who are world renowned scientific experts in the fields of 3D biofabrication, stem cell and developmental biology, tissue engineering, immunology, and nephrology.
  • The composition of our advisory board reflects that approach, and we are proud to have them join us and help guide the effort, said Ben Shepherd, Co-Founder and CEO of Trestle.
  • In addition, Laura Niklason, M.D., Ph.D., Co-Founder and CEO of Humacyte has agreed to join the Trestle advisory board.

Trestle Biotherapeutics Announces License Agreement with Kumamoto University for Key Stem Cell Biology Technology for Regenerative Medicine

Retrieved on: 
Tuesday, February 15, 2022
Research, Genetics, Stem Cells, Biotechnology, Health, University, General Health, Science, Education, Potency (pharmacology), Patient, CEO, Developmental biology, School, Kidney, Kidney failure, Entrepreneurship, Protalix BioTherapeutics, CSO, Education, Dialysis, Therapy, Technology, Institute, Survival, Transplant, Partnership, Kumamoto University, Research, Embryology, Industry, Pharmaceutical industry, Trestle bridge, Genetics, Trestle Biotherapeutics, Kumamoto University, TRESTLE BIOTHERAPEUTICS, KUMAMOTO UNIVERSITY

Trestle Biotherapeutics , a private company based in San Diego, today announced that it has entered into a license agreement with Kumamoto University.

Key Points: 
  • Trestle Biotherapeutics , a private company based in San Diego, today announced that it has entered into a license agreement with Kumamoto University.
  • Under the agreement, Trestle will gain access to foundational methods for the generation of specialized kidney cell types from human pluripotent stem cells.
  • Dr. Nishinakamura is a world-renowned kidney developmental biologist and a pioneer in the fields of kidney stem cell differentiation and organoid biology.
  • Trestle is building these novel tissue therapeutics through the integration of stem cell biology and 3D biofabrication technologies.

Trestle Biotherapeutics Licenses Innovations from Harvard University to Develop 3D Biofabricated Tissues to Treat Kidney Failure

Retrieved on: 
Tuesday, February 8, 2022
Research, General Health, University, Genetics, Education, Public Relations, Investor Relations, Clinical Trials, Science, Biotechnology, Communications, Other Science, Health, Kidney, Bioinspiration, Harvard John A. Paulson School of Engineering and Applied Sciences, Developmental biology, Harvard Medical School, Solution, Protalix BioTherapeutics, Wyss, Technology, Patient, Faculty, Applied science, Survival, Tissue, Bionics, CEO, SEAS, Hospital, Wyss Institute for Biologically Inspired Engineering, Therapy, Entrepreneurship, Kidney failure, Dialysis, Regenerative medicine, Harvard University, Laboratory, Massachusetts General Hospital, Nature, Transplant, Wyss Institute, Pharmaceutical industry, Dentistry, Engineering, Trestle bridge, Brigham, Yoshiko Morizane, DRS

Trestle Biotherapeutics , a private company based in San Diego, today announced that it has entered into a license agreement with Harvard University.

Key Points: 
  • Trestle Biotherapeutics , a private company based in San Diego, today announced that it has entered into a license agreement with Harvard University.
  • Trestle is developing functional kidney tissue to supplement and replace lost renal function in kidney failure patients.
  • Trestle is building these novel tissue therapeutics through the integration of stem cell biology and 3D biofabrication technologies.
  • Trestle was founded with the belief that recreating patterns and processes found in nature is key to building functional tissues.

Marsello Receives New Investment to Help Further Support Strategic Growth

Retrieved on: 
Tuesday, January 19, 2021
ATLAS-I, Electronic test equipment, Pulsed power, Trestle bridge, Technology

Retailers using Marsello are currently generating more than 45 times return over theirsubscription fee.

Key Points: 
  • Retailers using Marsello are currently generating more than 45 times return over theirsubscription fee.
  • The infusion of capital from Trestle will be instrumental in helping Marsello scale its business and further support the growth of the company's platform.
  • "We're stoked that Trestle has demonstrated confidence in Marsello as we've continued to grow strongly through this challenging year and provided us with the capital and expertise to further accelerate growth," said Brent Spicer, Co-founder and Co-CEO of Marsello.
  • Jack Fennebresque, Managing Partner of Trestle, added, "What became immediately evident to us is the meaningful and calculable return on investment the Marsello platform generates for its customers.

$110 Million Verdict for Cyclist Paralyzed by Falling Railroad Tie

Retrieved on: 
Tuesday, April 9, 2019
Metropolitan Transportation Authority, New York City Transit Authority, Transportation in New York City, Trestle bridge, 42nd Street Shuttle, 9

9, 2019 /PRNewswire/ --A cyclist paralyzed by a falling piece of railroad tie received justice today, as a Brooklyn jury awarded him a $110,174,972.38 verdict, nearly three years after the tragic accident.

Key Points: 
  • 9, 2019 /PRNewswire/ --A cyclist paralyzed by a falling piece of railroad tie received justice today, as a Brooklyn jury awarded him a $110,174,972.38 verdict, nearly three years after the tragic accident.
  • It was a busy two-way street with storefronts, apartments, and an elevated train trestle overhead.
  • The NYCTA had not assigned a worker to the area to warn pedestrians, cyclists, and motorists to stay away.
  • On that day, the NYCTA supervisor had two workers drag a 10-foot railroad tie to the edge of the girder and drop it into a hole.